Precision BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	68	43	132	450	438	705
Market Cap Growth	-	-67.12%	-70.64%	2.74%	-37.96%	-
Enterprise Value	-51	-76	-33	315	358	525
PE Ratio	-0.71	-0.71	-1.18	-14.69	-4.01	-7.59
PS Ratio	1.41	0.89	5.26	3.89	18.02	31.72
PB Ratio	3.65	2.30	2.19	4.93	9.85	5.10
P/FCF Ratio	-0.50	-0.50	-2.69	-28.27	-4.74	-7.37
P/OCF Ratio	-0.52	-0.52	-2.89	-41.43	-5.01	-9.93
EV/Sales Ratio	-1.57	-1.57	-1.30	2.73	14.76	23.59
EV/EBITDA Ratio	1.50	1.50	0.32	-15.54	-3.61	-6.00
EV/EBIT Ratio	1.29	1.29	0.29	-10.34	-3.29	-5.66
EV/FCF Ratio	0.89	0.89	0.66	-19.81	-3.88	-5.48
Debt / Equity Ratio	0.47	0.47	0.41	0.10	0.24	-
Debt / EBITDA Ratio	-0.17	-0.17	-0.25	-0.45	-0.11	-
Debt / FCF Ratio	-0.10	-0.10	-0.51	-0.57	-0.11	-
Quick Ratio	2.59	2.59	3.19	4.01	2.33	6.75
Current Ratio	2.73	2.73	3.34	4.50	2.47	7.19
Asset Turnover	0.27	0.27	0.10	0.50	0.14	0.10
Interest Coverage	-26.50	-26.50	-99.48	-230.83	-	-509.31
Return on Equity (ROE)	-200.80%	-200.80%	-140.60%	-34.80%	-141.20%	-77.60%
Return on Assets (ROA)	-34.50%	-34.50%	-45.20%	-13.10%	-60.80%	-39.80%
Return on Capital (ROIC)	-157.79%	-157.79%	-72.97%	-39.27%	-199.89%	-63.05%
Earnings Yield	-89.11%	-141.25%	-84.55%	-6.81%	-24.91%	-13.17%
FCF Yield	-124.92%	-198.02%	-37.16%	-3.54%	-21.11%	-13.56%
Buyback Yield / Dilution	-31.11%	-31.11%	-49.77%	-12.79%	-23.91%	-166.18%
Total Shareholder Return	-31.11%	-31.11%	-49.77%	-12.79%	-23.91%	-166.18%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).